Recon: Baxter increases allocations of IV fluid amid shortages; GSK to settle 80,000 Zantac lawsuits for as much as $2.2B
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States